WeVote
Log In

Bill

Bill

SB 6

Controlled substances: xylazine.

2025-2026 Regular Session Introduced by Angelique Ashby

California bill to classify xylazine, a veterinary drug increasingly found in illicit drugs, as a controlled substance to combat contaminated drug supplies and overdoses.

August 29 hearing: Held in committee and under submission.
#controlledsubstances #xylazine
0
WeVote Research Nonpartisan
Bill Summary · SB 6

Legislative bill overview

SB 6 proposes to add xylazine, a veterinary sedative increasingly found in illicit drug supplies, to California's list of controlled substances. The bill appears designed to address the growing public health threat posed by xylazine contamination in street drugs, particularly fentanyl and heroin.

Why is this important

Xylazine has emerged as a significant concern in overdose deaths and emergency room visits across multiple states. Classifying it as a controlled substance would give law enforcement and public health agencies clearer authority to track, regulate, and prosecute its illegal distribution, while potentially supporting treatment and harm reduction efforts.

Potential points of contention

  • Unintended consequences for veterinary use: Scheduling xylazine could complicate legitimate veterinary and medical uses if not carefully exempted, potentially affecting animal care access
  • Limited effectiveness against illicit supply: Critics may argue that scheduling alone doesn't address supply chain vulnerabilities or why xylazine is mixed into drugs, and may simply redirect production or substitution
  • Treatment and harm reduction focus: Some advocates may contend the bill emphasizes criminalization over investment in addiction treatment, overdose prevention sites, and naloxone distribution

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.